نتائج البحث

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry

• Authors : Nabi, Hafsah; Hendricks, Oliver; Jensen, Dorte Vendelbo

Subjects: Arthritis; Psoriatic/diagnosis; Rheumatoid/diagnosis

• Source: Nabi , H , Hendricks , O , Jensen , D V , Loft , A G , Pedersen , J K , Just , S A , Danebod , K , Munk , H L , Kristensen , S , Manilo , N , Colic , A , Linauskas , A , Thygesen , P H , Christensen ,

تفاصيل العنوان

The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars

• Authors : Jensen, Thomas Bo; Bartels, Dorthe; Sædder, Eva Aggerholm

Subjects: Anti-TNF drugs; Biological drugs; Biosimilars

• Source: Jensen , T B , Bartels , D , Sædder , E A , Poulsen , B K , Andersen , S E , Christensen , M M H , Nielsen , L & Christensen , H R 2020 , ' The Danish model for the quick and safe implementation of

تفاصيل العنوان

Discontinuing Infliximab in Benign Crohn’s Disease:A Real-Life Population-Based Cohort Study

• Authors : Larsen, Lone; Drewes, Asbjørn Mohr; Fallingborg, Jan

• Source: Larsen , L , Drewes , A M , Fallingborg , J , Jacobsen , B A , Karzoun , D S , Poulsen , H B & Jess , T 2020 , ' Discontinuing Infliximab in Benign Crohn’s Disease : A

تفاصيل العنوان

Comparative effectiveness of certolizumab pegol, abatacept and biosimilar infliximab in patients with rheumatoid arthritis treated in routine care. Observational data from the Danish DANBIO registry emulating a randomized trial

• Authors : Grøn, Kathrine L; Glintborg, Bente; Nørgaard, Mette

• Source: Grøn , K L , Glintborg , B , Nørgaard , M , Mehnert , F , Østergaard , M , Dreyer , L , Krogh , N S , Bjorner , J B & Hetland , M L 2019 , ' Comparative effectiveness of certolizumab pegol,

تفاصيل العنوان

Individualized therapy is long-term cost-effective compared to dose intensification in Crohn's disease patients failing infliximab

• Authors : Steenholdt, C.; Brynskov, J.; Thomsen, O. Ø.

• Source: Steenholdt , C , Brynskov , J , Thomsen , O Ø , Munck , L K , Fallingborg , J , Christensen , L A , Pedersen , G , Kjeldsen , J , Jacobsen , B A , Oxholm , A S , Kjellberg , J & Ainsworth , M 2015 ,

تفاصيل العنوان

Adalimumab and infliximab levels in neonates (ERA study)

• Authors : Juulsgaard, M.; Christensen, L. A.; Gibson, P. R.

• Source: Juulsgaard , M , Christensen , L A , Gibson , P R , Gearry , R , Fallingborg , J , Kjeldsen , J , Wildt , S , Svenningsen , L , Connell , W , Hvas , C L , Sparrow , M P , Walsh , A , Connor , S J ,

تفاصيل العنوان

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis:results from the nationwide registries DANBIO and ICEBIO

• Authors : Glintborg, Bente; Gudbjornsson, Bjorn; Steen Krogh, Niels

• Source: Glintborg , B , Gudbjornsson , B , Steen Krogh , N , Omerovic , E , Manilo , N , Holland-Fischer , M , Lindegaard , H M , Gitte Loft , A , Nordin , H , Johnsen , L , Flejsborg Oeftiger , S , Hansen ,

تفاصيل العنوان

Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis:Individual Participant Data Meta-Analyses of Clinical Trials

• Authors : Agrawal, Manasi; Petralia, Francesca; Tepler, Adam

Subjects: clinical trial data; gender; individual participant data

• Source: Agrawal , M , Petralia , F , Tepler , A , Durbin , L , Reinisch , W , Colombel , J-F & Shah , S C 2023 , ' Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for

تفاصيل العنوان

Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline

• Authors : Kawano-Dourado, Leticia; Kristianslund, Eirik Klami; Zeraatkar, Dena

Subjects: Humans; Drug Monitoring/methods; Inflammatory Bowel Diseases/drug therapy

• Source: Kawano-Dourado , L , Kristianslund , E K , Zeraatkar , D , Jani , M , Makharia , G , Hazlewood , G , Smith , C , Jess , T , Stabell , C , Schatten , A , Owen , A , Gehin , J , Katsidzira , L ,

تفاصيل العنوان

Validation of the pharmacokinetic model for anti- TNFα clearance in infants exposed to anti- TNFα during pregnancy

• Authors : Wieringa, Jantien W.; Kruizinga, Matthijs D.; Driessen, Gertjan J. A.

Subjects: Anti-tumour necrosis factor alpha; clearance; inflammatory bowel disease

• Source: Wieringa , J W , Kruizinga , M D , Driessen , G J A , van der Woude , C J & Julsgaard , M 2024 , ' Validation of the pharmacokinetic model for anti- TNFα clearance in infants exposed to anti- TNFα

تفاصيل العنوان